Xingguo Zhong

Dr. Xingguo Zhong


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2010 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
XZXingguo Zhong
Xingguo Zhong
MXMaoming Xiong
Maoming Xiong
XMXiangling Meng
Xiangling Meng
RGRenhua Gong
Renhua Gong
Background: To compare the biological characteristics of three types of human hepatocellular carcinoma multi-drug resistant cell sub-lines Bel-7402/ADM models established by three methods. Methods: Established human hepatocellular carcinoma adriamycin (ADM) multi-drug resistant cell sub-lines models Bel-7402/ADMV, Bel-7402/ADML and Bel-7402/ADMS by three methods of in vitro concentration gradient increased induction, nude mice liver-implanted induction and subcutaneous-implanted induction respectively. Phase contrast microscopy was used to observe the cells and the MTT (methyl thiazolyl tetrazolium) method was used to detect drug resistance of the three different sub-lines of cells. Results: The three groups of drug resistant cells, Bel-7402/ADMV, Bel-7402/ADML and Bel-7402/ADMS generated cross-resistance to ADM and CDDP (cis-Diaminedichloroplatinum), but showed a significant difference in resistance to Bel-7402 IC50 value (P < 0.01). The doubling times were significantly extended compared to the parent cell line (39 h) and were 65 h (Bel-7402/ADMV), 46 h (Bel-7402/ADML), and 45 h (Bel-7402/ADMS). The excretion rates of ADM were significantly increased compared with the parent cell (34.14%) line and were 81.06% (Bel-7402/ADMV), 66.56% (Bel-7402/ADML) and 61.56% (Bel-7402/ADMS). Expression of P-gp and MRP in the three groups of resistant cells was significantly enhanced (P < 0.01). There was no significant variation in the expression of GSH/GST (P > 0.05). Conclusions: Stable resistance was involved in the resistant cell line model established by the above three methods. Liver implantation was a good simulation of human hepatocellular and proved to be an ideal model with characteristics similar to human hepatocellular biology and the pharmacokinetics of anticancer drugs.

5 January 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YZYalong Zhang
Yalong Zhang
XZXingguo Zhong
Xingguo Zhong
LZLin Zhou
Lin Zhou
YFYuan Fang
Yuan Fang
TCTongqing Chen
Tongqing Chen
While fructose-1,6-diphosphate (FDP) has been clinically applied in ischemic conditions, its comprehensive effects on hemostasis remain to be fully elucidated. This in vitro study examined the influence of FDP on coagulation and platelet function using thromboelastography (TEG) across three platforms, coagulation factor assays, and platelet aggregation tests over a concentration range of 0–6 mg/mL. The results revealed that FDP concentration-dependently prolonged TEG R-time ( P < 0.01), with an increase of 21.8–48.3% at the clinically relevant concentration of 3.71 mg/mL. Strong inverse correlations were observed between FDP concentration and the activities of factors V, VII, IX, XI, and XII ( r  = − 0.989 to − 0.997, P < 0.001), whereas factors II, VIII, and X remained unaltered. Furthermore, FDP significantly inhibited platelet aggregation ( P < 0.001), nearly abolishing epinephrine- and ADP-induced aggregation at 6 mg/mL under unbuffered conditions. pH-control experiments confirmed that the anticoagulant effects were FDP-specific, while the antiplatelet effects were primarily mediated by FDP with a partial pH-dependent component. These findings demonstrate that FDP possesses dual anticoagulant and antiplatelet properties through selective inhibition of coagulation initiation factors and broad suppression of platelet responsiveness, suggesting potential implications for clinical use in high-risk populations and warranting further investigation.

22 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
YZYalong Zhang
Yalong Zhang
XZXingguo Zhong
Xingguo Zhong
LZLin Zhou
Lin Zhou
YFYuan Fang
Yuan Fang
TCTongqing Chen
Tongqing Chen
Objective To investigate the effects of sodium fructose diphosphate (FDP) on blood coagulation reaction time and plasma coagulation factor activity in vitro. Method The thromboelastogram detection system provided by three different manufacturers (Maiketian, Lepu, and Dingrun) was used to determine the blood coagulation reaction time (R) , clotting time (K), α-angle, and maximal amplitude (MA) of blood samples mixed with different concentrations FDP and the samples before dosing.The activities of coagulation factors II, V, VII, VIII, IX, X, XI and XII for plasma mixed with FDP were determined by automatic hemagglutination analysis system. The difference of test results between the experimental group with FDP and the control group without FDP was compared. The correlation between FDP concentration and the results of thrombologram or coagulation factor activity was analyzed by linear regression. New Zealand white rabbits were selected for the experiment on the effect of the drug on blood coagulation in vivo, and the changes of the thrombologram test results (R, K, α-angle, MA) at each time point after injection of FDP groups with the same dose were analyzed. According to the changes of the thrombologram test results before and after injection, statistical analysis was conducted to determine whether there were statistical differences in the effect of the drug on blood coagulation function. Result The results of thrombologram provided by three different manufacturers showed that the R value of blood sample was significantly correlated with the blood FDP concentration (P < 0.000), and the correlation coefficient r was 0.988 (Maiketian), 0.999 (Lepu) and 0.996 (Dingrun), respectively. There was no significant correlation between FDP concentration and K, α-angle , or MA (P > 0.05). The results of in vitro experiments showed that plasma coagulation factor V, VII, IX, XI and XII activities were significantly negatively correlated with plasma FDP concentrations (P < 0.000), and the correlation coefficients r were -0.995, -0.990, -0.989, 0.997, 0.995, respectively. The activities of II, VIII and X were not significantly affected by FDP (P > 0.05). In vivo experiments of New Zealand white rabbits showed that 0.5h after intravenous 0.5g/Kg FDP administration , 0.5h, 1h and 1.5h after 1g/Kg administration, 0.5h, 1h and 1.5h after 2g/Kg administration, and 0.5h, 1h, 1.5h and 2h after 4g/Kg administration, there were statistical differences in the R values of thrombologram compared with those before administration (P < 0.05), and the R values increased significantly after administration. That is, the blood coagulation reaction time is prolonged. Conclusion FDP can affect the results of blood coagulation test in vivo and vitro. It may really affect the function of our coagulation system.

27 February 2025 in medRxiv
Verified
Preprint
Open access
PDF file
YZYalong Zhang
Yalong Zhang
XZXingguo Zhong
Xingguo Zhong
LZLin Zhou
Lin Zhou
NHNing He
Ning He
YFYuan Fang
Yuan Fang
TCTongqing Chen
Tongqing Chen
Objective: To investigate the effects of sodium fructose diphosphate (FDP) on blood coagulation parameters, including reaction time and plasma coagulation factor activity, in both in vitro and in vivo models. Methods: Three thromboelastography systems (Maiketian, Lepu, Dingrun) were used to assess coagulation parameters (reaction time [R], clotting time [K], α-angle, maximal amplitude [MA]) in blood samples spiked with varying FDP concentrations. An automatic coagulation analyzer quantified the activities of coagulation factors II, V, VII, VIII, IX, X, XI, and XII in FDP-treated plasma.Differences between FDP-treated and control groups were statistically compared. Linear regression analyzed correlations between FDP concentrations and coagulation parameters. For in vivo studies, New Zealand white rabbits received intravenous FDP (0.5, 1, 2, or 4 g/kg), and thromboelastography parameters were monitored at multiple time points post-administration (0.5-2 hours). Results: Thromboelastography demonstrated a strong positive correlation between FDP concentration and R values across all systems ( P < 0.001; r = 0.988 [Maiketian], 0.999 [Lepu], 0.996 [Dingrun]). No significant associations were observed between FDP and K, α-angle, or MA ( P > 0.05). In vitro experiments revealed significant negative correlations between FDP concentration and activities of factors V ( r = -0.995), VII ( r = -0.990), IX ( r = -0.989), XI ( r = -0.997), and XII ( r = -0.995) ( P < 0.001), while factors II, VIII, and X remained unaffected ( P > 0.05). In vivo administration demonstrated dose-dependent prolongation of R-time, reaching statistical significance (p < 0.05) at:0.5 g/kg: 0.5 hr post-dose,1 g/kg: 0.5-1.5 hr,2 g/kg: 0.5-1.5 hr,4 g/kg: 0.5-2 hr. Conclusion: FDP significantly impacts coagulation testing outcomes both in vitro and in vivo, potentially through modulation of intrinsic pathway factors (V, VII, IX, XI, XII) and direct interference with clot initiation. These findings suggest clinically relevant anticoagulant properties that warrant further investigation.